U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07133074) titled 'Allergy Delabeling in Antibiotic Stewardship - Intervention' on June 16.
Brief Summary: The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patients with a hematologic malignancy.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Beta Lactam Allergy
Hematologic Malignancy
Intervention:
DIAGNOSTIC_TEST: RENEW-IN Algorithm for assessment of a beta-lactam intervention
The RENEW-IN intervention includes a detailed assessment of the participant's beta-lactam allergy history and determination of a risk-level for all...